Research Article
CYC1 Predicts Poor Prognosis in Patients with Breast Cancer
Table 1
The clinicopathological parameters of all cases.
| | Clinical characteristics | | % | |
| Breast malignant tumor | Gender | Male | 0 | 0% | — | Female | 26 | 100% | Age | ≤50 | 12 | 46% | 0.31 | >50 | 14 | 54% | Pathology | Intraductal carcinoma | 26 | 100% | — | Histological grade | I | 3 | 12% | — | II | 16 | 62% | III | 4 | 15% | ER | Negative | 13 | 50% | 0.885 | Positive | 13 | 50% | PR | Negative | 13 | 50% | 0.66 | Positive | 13 | 50% | HER2 | Negative | 7 | 27% | 0.3 | Positive | 19 | 73% | Lymph node | Negative | 13 | 50% | 0.02 | Positive | 13 | 50% |
| Breast benign tumor | Gender | Male | 3 | 30% | — | Female | 7 | 70% | Age | <50 | 3 | 30% | — | ≥50 | 7 | 70% | Pathology | Hyperplasia | 4 | 40% | — | Intraductal papilloma | 1 | 10% | Cystic disease and hyperplasia | 3 | 30% | Fibroadenoma | 2 | 20% |
|
|
and this was considered statistically significant.
|